Lucida boasts some of the foremost experts in AI technology and radiology,
from leading clinical institutes across Europe.
Our core team boasts more than twenty man years experience in AI software development and some 100 man years experience in the domain of medical imaging, both in terms of clinical practice and market development.
Dr Antony Rix
CEO & Co-Founder
PhD Machine learning and AI
Co-founder, Psytechnics (acquired 2011 by Netscout) – patented AI & International standard
Senior Consultant, TTP; CEO & Co-founder, 8power
Expert in software, medical devices & AI development
Professor Evis Sala
Chief Medical Officer & Co -founder
Professor of Oncological Imaging, University of Cambridge & Addenbtooke’s Hospital
Built body imaging capability at Memorial Sloan Kettereing Cancer Centre / Weill Cornell
KOL relationships in the USA
Board Certified radiologist
Expert in cancer imaging, radiogenomics & AI
Medical Imaging Entrepreneur
Partner, London Uroradiology
Co-founder of multiple medical imaging and biopsy businesses.
Co-founder, Nuada Medical Group, the pioneer of prostate MRI in private practice 2009 – 2015.
Ran Philips Medical Global Service business 1998 – 2001
Market & business development
Co-founder, Prostate Matters
Co-founder, Nuada Medical Group 2009 – 2018
Co-founder, Market Equity Ltd a collaboration with Cranfield School of Management 1994 – 2018
Extensive global go-to-market experience with diagnostic imaging companies
Outstanding network of relationships across the prostate diagnosis and treatment market in the UK and Europe
Professor Anwar Padhani
Professor at the Institute of Cancer Research & Mount Vernon Hospital.
An international authority on MRI prostate & whole body imaging & cancer imaging
Co-chair, International PI-RADS (prostate imaging) standards group
Dr Guiseppe Petralia
European Oncology Institute (IEO) & University of Milan
Expert on prostate & whole body MRI & cancer screening
We collaborate with Cambridge University, we are a partner in the ReIMAGINE prostate imaging trial, are in the process of establishing collaborative partnerships with several UK NHS Trust hospitals to help further develop and validate and test Pi, our AI system for detecting prostate cancer from MRI.